Most medical patients with opid use disorders do not receive the recommended treatment.
A recent study Health issues Testing how medical patients are well treated with opid use disorders and found that the results are disturbing. Researchers looked at medical entry, claims, and encounter data for 2020, focusing on whether the beneficiaries of the defect of the opium use are being taken care of, which meets the eight -nation recognized standards, and the data is clearly shown. In fact, less than 40 % of the patients were treated that meets these quality measures. When comparing different types of medical coverage, Medicare Adventage performed worse than a service medical service for traditional fees in six of the eight. The study also found that Medicide usually provided high quality care than medical for some of the steps that could be compared.
The results of this study show how medical opioid use is reduced to the treatment of patients. In almost all steps, less than 30 % of patients were treated, which met the proposed standards, and even high -performing measures were not more than 40 %. These results suggest that people benefiting from medical are less likely to get high quality opid treatment than medical beneficiaries, which indicate an important search in research on this population. Earlier, the study of medicier was mostly focused on the number of beneficiaries who receive medication drugs for the use of opioid use, which does not make other quality measures widespread non -searches.
Many strategies can help improve medical treatment. Increasing medical coverage and encouraging more providers to treat patients with opid use disorders can increase access to care. Programs that improve follow -up care after entering hospitals or after emergency visits can help patients get busy treatment. Efforts to inform patients about the benefits of treatment options and maintenance can also increase participation. Many people with opid use disorder do not want to be treated because they are not sure it will help, so out rech and education can be an important part of improving the consequences.
The pre -allowed requirements for opid treatment have been identified as a major obstacle. Providers have reported that additional paperwork and approval process discourage them from treating medical patients. These requirements have been shown to enhance access to medicines such as boronphine and methadone. Another approach to improve access is to increase the number of providers who can write these medicines. In 2022, about one -third of the US counties, there was no provider in the counties that treated medical patients with these medicines. Change in federal policy, such as eliminating the need for X -wire to suggest bupinorphin, has increased the number of prescriptions, which shows that policy adjustment can make a real difference.
Emergency department programs are also demonstrating promises. Patients with opid use disorder in the emergency department can be started immediately on the medicines and can be linked to the ongoing treatment after discharge. These programs, which are often called the Bridge Program, help maintain the continuity of care and increase the possibility that the patients will be in treatment.
Overall, the study shows that medical patients are less to help patients in the use of opioid use. This makes it clear that these patients are not treating which meets national standards. Religious monitoring of quality measures can help to identify the flaws in the care and inform the policies policies to improve access and results. By reducing obstacles, increasing the availability of the provider, and supporting follow -up care, medical can help more patients get the treatment needed to recover from the use of opioids.
Sources:
Medicare is the quality of the treatment of opioid use disorder and is behind the medicid
States, tribal communities to OPED Response Grant HHS Awards $ 1.5 Billion Awards
